RNA Competitive landscape Report 2022 by DelveInsight

RNA pipeline constitutes 85+ key companies continuously working towards developing 100+ RNA treatment therapies, analyzes DelveInsight

 


Ribonucleic acid (abbreviated RNA) is a nucleic acid present in all living cells that has structural similarities to DNA. Unlike DNA, however, RNA is most often single-stranded. An RNA molecule has a backbone made of alternating phosphate groups and the sugar ribose, rather than the deoxyribose found in DNA. 

 

DelveInsights, “RNA Competitive landscape, 2022,” report provides comprehensive insights about 85+ companies and 100+ RNA drugs in the RNA Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Some facts of RNA Competitive landscape report:



  • Leading RNA Companies working in the market are Alnylam Pharmaceuticals, Suzhou Ribo Life Sciences, Arrowhead Pharmaceuticals, Sylentis, Vir Biotechnology, Arbutus Biopharma, Silenseed, OliX Pharmaceuticals, Bio-Path Holdings, Janssen Pharmaceuticals, Eli Lilly and Company, Dicerna Pharmaceuticals, Amgen, Sirnaomics, Silence Therapeutics, Sylentis, Aro Biotherapeutics and Others.



  • Key RNA therapies in various stages of development include Fitusiran, ARO-APOC3, LY3561774, DCR-HBVS, VIR-2218, Zilebesiran, OLX 101A and Others.



  • In November 2021, Arrowhead Pharmaceuticals announced that it entered into an exclusive license agreement with GSK under which GSK will develop and commercialize ARO-HSD.

 

To know more about the RNA Pipeline Analysis report, click here: RNA Competitive landscape

 

DelveInsight’s RNA Report covers around 100+ products under different phases of clinical development like

  • Assessment by RNA Product Type
  • Assessment by Stage and Product Type of RNA
  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration of RNA
  • Assessment by RNA Molecule Type
  • Assessment by Stage and Molecule Type of RNA

 

Emerging RNA Drugs Under Different Phases of Clinical Development Include:

 

Some of the RNA therapies are Vutrisiran, OLX 101A and Many Others.

 

 

Further RNA product details are provided in the report. Download the RNA Pipeline report to learn more about the emerging RNA therapies at: https://www.delveinsight.com/report-store/rna-competitive-landscape

 

 

Key companies in the RNA Therapeutics Market:

 

Some of the RNA Companies working in the market are Alnylam Pharmaceuticals, Suzhou Ribo Life Sciences, Arrowhead Pharmaceuticals, Sylentis, Vir Biotechnology, Arbutus Biopharma, Silenseed, OliX Pharmaceuticals, Bio-Path Holdings, Janssen Pharmaceuticals, Eli Lilly and Company, Dicerna Pharmaceuticals, Amgen, Sirnaomics, Silence Therapeutics, Sylentis, Aro Biotherapeutics and Others.

 

Request for Sample PDF Report to know in detail about the recent developments  and advancements in RNA clinical trials - https://www.delveinsight.com/report-store/rna-competitive-landscape

 

Table of Content (TOC)

 

1. RNA Pipeline Report Introduction

2. RNA Pipeline Report Executive Summary

3. RNA Pipeline: Overview

4. Analytical Perspective In-depth Commercial Assessment

5. RNA Clinical Trial Therapeutics

6. RNA Pipeline: Late Stage Products (Pre-registration)

7. RNA Pipeline: Late Stage Products (Phase III)

8. RNA Pipeline: Mid Stage Products (Phase II)

9. RNA Pipeline: Early Stage Products (Phase I)

10. RNA Pipeline Therapeutic Assessment

11. Inactive Products in the RNA Pipeline

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Key RNA Companies

14. Key Products in the RNA Pipeline

15. Unmet Needs

16. RNA Market Drivers and Barriers

17. Future Perspectives and Conclusion

18. Analyst Views

19. Appendix

 

Download Sample PDF Report to know more about @ RNA drugs and medication

 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t...
Read more

Cervical Intraepithelial Neoplasia Market and Epidemiology 2032 by DelveInsight

DelveInsight's " Cervical Intraepithelial Neoplasia Market Insights, Epidemiology, and Market Forecast-2032 " report delivers an in-depth understanding of Cervical Intraepithelial Neoplasia, historical and forecasted epidemiology as well as the Cervical Intraepithelial Neoplasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Cervical Intraepithelial Neoplasia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Cervical Intraepithelial Neoplasia market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Cervical Intraepithelial Neoplasia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Cervical Intraepithelial Neoplasia market. Request for a Free Sample Report: Cervic...
Read more

The Need And The Importance Of The Healthcare Reports for the Pharma Companies

Image
It is very important for the hospitals and the other medical institutions to preserve and keep the healthcare reports of all the patients very safe and secure. All the medical records are being kept by almost all of these institutes. As a matter of fact, the healthcare reports are very important for comprehending the medical history of the patient. If he or she suffers from the same ailment once more the previous reports will be absolutely indispensible while treating him or her. Nowadays, with the advancement of technology the manual records are slowly and gradually getting digitalized. It is easier to store and preserve the digital records than the manual and the physical ones.  Choosing The Best And The Most Professional Services For Healthcare Reports: • Rising Pharma Market for You Now In the market there are a host of companies that preserves the healthcare reports of the various patients. All of it is now being done in the digital format due to the adv...
Read more